The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…
Read MorePharmaceuticals
VA Enters Into Development Partnership with Hoth Therapeutics
The biopharmaceutical company will research treatments for obesity and linked health conditions. The Department of Veterans Affairs (VA) recently finalized an agreement with biopharmaceutical company Hoth Therapeutics, which…
Read More
Justice Department Sues CVS Over Prescription Metric Boosting
The department claims the practice contributed to the rise in opioid-related deaths. The Department of Justice (DOJ) sued CVS Health last week, alleging that the company knowingly filled…
Read More
Pharmaceutical Companies Request Recusal of FTC Chair from Insulin Case
They claim she and other commissioners are prejudiced against pharmaceutical companies. This week, the top three pharmaceutical companies in the United States requested that Lina Khan, chair of…
Read More
Supreme Court Declines Appeal by Former Pharma Executive
The court upholds the $64 million penalty, holding the former CEO liable for price gouging and fraud. The Supreme Court declined to hear an appeal filed by former…
Read MoreHHS Adds 54 Drugs to Medicaid Drug Rebate Program
Drugs will have a lowered coinsurance rate for 822,000 enrollees. The Department of Health and Human Services (HHS) announced that 54 drugs have been added to Medicaid’s Drug…
Read More
HHS Reports Lower Medicare Prices on 10 Drugs
The deal is expected to save billions for Medicare and reduce out-of-pocket costs for millions of seniors starting in 2026. The Department of Health and Human Services (HHS)…
Read More
FDA Schedules Panel Meeting on Alzheimer’s Drug
The June meeting was scheduled after expedited approval was denied. The Food and Drug Administration (FDA) announced this week that it has scheduled a meeting of the Peripheral…
Read More
FDA Approves Duchenne Muscular Dystrophy Treatment for Children
Duvyzat receives approval under fast-track designation. The U.S. Food and Drug Administration (FDA) has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne Muscular Dystrophy…
Read More
FDA Warns Against Over-the-Counter Pain Relief Products for Cosmetic Procedures
Six companies receive warning letters as the FDA addresses unsafe topical analgesics and urges consumer vigilance. The U.S. Food and Drug Administration (FDA) has cautioned against using specific…
Read More